Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer. - Wikidata - wikimedia - TriplyDB

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

http://www.wikidata.org/entity/Q37658406

about

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

http://www.wikidata.org/entity/Q37658406

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@en

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@nl

type

label

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@en

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@nl

prefLabel

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@en

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@nl

P1433

Q37658406-6495FA81-19C2-4176-BB7B-670283CA9F7D

P1476

Q37658406-65DACEB1-2B33-46E7-A6F2-7A919A07923E

P2093

Q37658406-1DA30CEC-5B8F-4236-B38A-700E3887E61D

Q37658406-27837B76-382F-4A29-89B6-D3C94644D9BB

Q37658406-44BAD6B3-D085-4384-8B63-85F8CF3506F4

Q37658406-5A7A29E2-9AD9-4936-AFB5-2664FC9389FB

Q37658406-648B0DA8-9713-4D1F-9B6F-9E014ED0C0CE

Q37658406-6F1C496E-43FD-4B65-A2E2-69E1F4528E0F

Q37658406-AFBE65F7-727A-4731-975D-4F6D1842F30C

Q37658406-BD123FEE-5F8E-4072-A274-F8CF99EA8EA2

Q37658406-DF563BA8-54FB-475F-AA34-837B176206CE

P2860

Q37658406-045326F8-B346-45FB-AB4D-C60A126CB158

Q37658406-12A4B2C5-4E5C-4CBC-96D4-0AB50603A85B

Q37658406-175FC655-CEA6-411E-A05E-B00F540DE241

Q37658406-190678E8-9BDD-49D5-BCB2-1930CE231625

Q37658406-226475D4-3BBB-48B0-AFE2-3075DE520355

Q37658406-31366C97-FC27-4D20-A7C6-E9B4EAFA3A7A

Q37658406-315B0DCB-6459-45C4-B71D-F21F60780B5F

Q37658406-3E42BCC4-2278-4A84-9DD0-67B3B7A92A30

Q37658406-47D07F25-7EDC-41D1-98E2-B4BC32167287

Q37658406-48215711-C67F-4E0A-BDED-51381125D000

P2888

Q37658406-7F227546-F6F6-4002-8A29-6246AD30E800

P304

Q37658406-7BC9E383-EE35-453E-8227-47AFDDB83609

P31

Q37658406-C4732963-2BF9-4FA3-8689-8AEC435881DE

P356

Q37658406-43C1D7E1-B6D7-4B3A-8CBD-EA21225C2693

P433

Q37658406-351BBD00-4289-48A1-BB19-A3E5E8EF0B6E

P478

Q37658406-B8FDB1A8-B021-4A4E-A417-B8EA8440395C

P50

Q37658406-B249263A-6AF7-4B65-B7F7-DC7FFFEE2794

P577

Q37658406-C01F5932-3208-4297-AD30-DB0DABA50591

P6179

Q37658406-C8A0EB19-3B02-4C3C-A414-98E184F873BB

P698

Q37658406-79D02CD3-B9E8-4D7D-BE73-89B847D9E711

P932

Q37658406-31295139-C9D9-4B01-9FBB-772C7012A5F6

P356

S12957-017-1117-4

P1433

World Journal of Surgical Oncology

P1476

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

@en

P2093

Antonia Schulte

http://www.w3.org/2001/XMLSchema#string

Christian Haverkamp

http://www.w3.org/2001/XMLSchema#string

Cordula Annette Jilg

http://www.w3.org/2001/XMLSchema#string

Kathrin Schaal

http://www.w3.org/2001/XMLSchema#string

Laura Heinicke

http://www.w3.org/2001/XMLSchema#string

Martin Werner

http://www.w3.org/2001/XMLSchema#string

Ulrich Wetterauer

http://www.w3.org/2001/XMLSchema#string

Vanessa Drendel

http://www.w3.org/2001/XMLSchema#string

Wolfgang Schultze-Seemann

http://www.w3.org/2001/XMLSchema#string

P2860

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

Diabetes and cancer: a consensus report.

β-Adrenergic Receptor Signaling in Prostate Cancer

Pre-treatment risk stratification of prostate cancer patients: A critical review.

Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.

Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.

The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.

Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients

P2888

s12957-017-1117-4

P304

50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-017-1117-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083854015

http://www.w3.org/2001/XMLSchema#string

P698

28222734

http://www.w3.org/2001/XMLSchema#string

P932

5320736

http://www.w3.org/2001/XMLSchema#string